HomeCARM • NASDAQ
Carisma Therapeutics Inc
add
$0.18
7.52%
After Hours:(5.61%)-0.0100
$0.17
Closed: May 15, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 3.65M | -14.83% |
Operating expense | 3.93M | -46.34% |
Net income | -17.64M | 15.86% |
Net profit margin | -482.75 | 1.21% |
Earnings per share | -0.42 | 12.50% |
EBITDA | -15.19M | 30.11% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 18.83M | -76.01% |
Total assets | 30.46M | -65.99% |
Total liabilities | 58.37M | -7.39% |
Total equity | -27.91M | — |
Shares outstanding | 41.79M | — |
Price to book | -0.29 | — |
Return on assets | -109.32% | — |
Return on capital | 238.51% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -17.64M | 15.86% |
Cash from operations | -8.35M | 48.11% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | -620.00K | -713.86% |
Net change in cash | -8.97M | -61.45% |
Free cash flow | -1.15M | 88.02% |
Previous close
$0.19
Day range
$0.16 - $0.21
Year range
$0.16 - $1.90
Market cap
7.57M USD
Avg Volume
363.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Headquarters
Website
Employees
46